NVAX Stock Up 5.7% Now, Novavax CEO Says Coronavirus Workers Could Get Vaccine This Year

Coinspeaker
NVAX Stock Up 5.7% Now, Novavax CEO Says Coronavirus Workers Could Get Vaccine This Year

Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate. NVAX stock is up.

NVAX Stock Up 5.7% Now, Novavax CEO Says Coronavirus Workers Could Get Vaccine This Year

Coinspeaker

51 total views, 1 views today

Author: toutiao